title: Effects of fibulin-5 on attachment, adhesion, and proliferation of primary human endothelial cells.
abstract: BACKGROUND
  Fibulin-5 is a novel extracellular protein that is thought to act as a bridging peptide between elastin fibers and cell surface integrins in blood vessel wall. Fibulin-5 binding to endothelial cell (EC) surface integrins may effect cell proliferation and cell attachment to extracellular matrix (ECM) or to artificial surfaces. In this paper, we describe the effects of fibulin-5 on attachment, adhesion, and proliferation of primary human EC. After demonstrating that fibulin-5 over-expression inhibited EC proliferation, we tested the hypothesis that co-expression of fibulin-5 and VEGF165 will lead to unique EC phenotype that will exhibit increased adherence properties and retain its proliferation capacity.
  
  
  RESULTS
  Fibulin-5 and VEGF165 gene transfer to primary human saphenous vein endothelial cells was accomplished using retroviral vectors encoding the two genes. Transgene expression was verified using immunohistochemistry, Western blotting, and ELISA. Fibulin 5 over-expression tended to improve immediate EC attachment (30 min after seeding) and improved significantly adhesion (>40%) under shear stress tested 24h after EC seeding. The effects of fibulin-5 and VEGF165 on EC proliferation in the presence or absence of basic FGF were also tested. EC expressing fibulin-5 had reduced proliferation while VEGF165 co-expression ameliorated this effect.
  
  
  CONCLUSIONS
  Fibulin-5 improved EC attachment to artificial surfaces. Dual transfer of fibulin-5 and VEGF165 resulted in EC phenotype with increased adhesion and improved proliferation. This unique EC phenotype can be useful for tissue engineering on endovascular prostheses.
authors.affiliation: Department of Cardiovascular Medicine, Lady Davis Carmel Medical Center, 7 Michal Street, Haifa 34632, Israel.
authors.forename: M
authors.initials: M
authors.lastname: Preis
authors.forename: T
authors.initials: T
authors.lastname: Cohen
authors.forename: Y
authors.initials: Y
authors.lastname: Sarnatzki
authors.forename: Y
authors.initials: Y
authors.lastname: Ben Yosef
authors.forename: J
authors.initials: J
authors.lastname: Schneiderman
authors.forename: Z
authors.initials: Z
authors.lastname: Gluzman
authors.forename: B
authors.initials: B
authors.lastname: Koren
authors.forename: B S
authors.initials: BS
authors.lastname: Lewis
authors.forename: Y
authors.initials: Y
authors.lastname: Shaul
authors.forename: M Y
authors.initials: MY
authors.lastname: Flugelman
mesh_terms: D002448:Cell Adhesion / Q000502:physiology; D049109:Cell Proliferation; D002469:Cell Separation; D002478:Cells, Cultured; D042783:Endothelial Cells / Q000166:cytology* / Q000378:metabolism / Q000502:physiology*; D004730:Endothelium, Vascular / Q000166:cytology / Q000378:metabolism / Q000502:physiology; D016326:Extracellular Matrix Proteins / Q000235:genetics / Q000502:physiology*; D018014:Gene Transfer Techniques; D006131:Growth Inhibitors / Q000235:genetics / Q000502:physiology*; D006801:Humans
chemical_list: D016326:Extracellular Matrix Proteins; C492373:FBLN5 protein, human; D006131:Growth Inhibitors